Manus Aktteva
We are only a phone call away, Call us on: +91 98791 67919
+91 99798 66376
Home
About Us Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, API, Intermediate, Nutraceuticals, Intermediates, Speciality chemicals, Advance level intermediatesEventsNewsEnquiryContact UsResources
Manus Aktteva, An ISO 9001:2008 Certified organization, is a well informed, highly efficient and swiftly functioning competitive sourcing entity. You may please send us a sourcing request on info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
API, Active Pharmaceutical Ingredients, Active Pharmaceutical Rawmaterials, Pharmaceutical Intermediates, Intermediates
Products A to Z
       
Search The Site
Please enter all or part of your keyword to retrive data
Search by: Chemical Name
  CAS#
  Molecular Formula
Quick Help
Services
Queries
Tel1: +91 98791 67919
Tel2: +91 99798 66376
Email: info@manusaktteva.in
Twitter  Facebook
Search Results for: M
Previous 1 - 15 | 16 - 30 | 31 - 45 | 46 - 60 | 61 - 75 | 76 - 76 | Next
1 Manidipine hydrochloride
Manus Aktteva offers Manidipine hydrochloride, 89226-75-5,for your requirements of RND & evaluation, along with its intermediates with supportive technical package required for evaluation for intermediates.
View Detail   |  List of Intermediates
2 Maraviroc
Manus Aktteva offers Maraviroc, 376348-65-1 for RND and its intermediates for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
3 Melanotan II
Manus Aktteva offers Melanotan II, 121062-08-6, for RND and its crude form for your evaluation requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
4 Meloxicam
Manus Aktteva offers Meloxicam,71125-38-7,for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail   |  List of Intermediates
5 Mercaptopurine
Mercaptopurine also called 6-Mercaptopurine, 6-MP is an immunosuppressive drug used to treat leukemia. It is also used for pediatric non-Hodgkin's lymphoma, polycythemia vera, psoriatic arthritis, and inflammatory bowel disease such as Crohn's Diseas....
View Detail   |  List of Intermediates
6 Mesna
Mesna is an adjuvant used in cancer chemotherapy involving cyclophosphamide and ifosfamide. Mesna is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cance....
View Detail   |  List of Intermediates
7 Methotrexate
Manus Aktteva offers Methotrexate, 59-05-2,with Technical Package & DMF for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail   |  List of Intermediates
8 Methylprednisolone Sodium Succinate Sterile USP
Manus Aktteva offers Methylprednisolone Sodium Succinate Sterile USP,2375-03-3,for your RND evaluation with supportive technical package required for evaluation. DMF also can be offered for this product
View Detail   |  List of Intermediates
9 Minodronic acid
Manus Aktteva offers Minodronic acid and its Intermediates for your RND evaluation requirements
View Detail   |  List of Intermediates
10 Mitoxantrone hydrochloride
Mitoxantrone is an anthracycline antineoplastic agent used in the treatment of certain types of cancer, mostly metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoma. Mitoxantrone is also used to treat multiple sclerosis most n....
View Detail   |  List of Intermediates
11 Montelukast sodium
Manus Aktteva offers Montelukast sodium, 151767-02-1,for your RND, Pilots and commercial requirements with supportive Drug master file
View Detail   |  List of Intermediates
12 Mycophenolate mofetil
Mycophenolate mofetil is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.
View Detail   |  List of Intermediates
13 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester
Manus Aktteva offers Bendamustine hydrochloride Intermediate,3543-73-5, 1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester,for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
14 1-Methylindole
Manus Aktteva offers 1-Methylindole, 603-76-9,for your requirements of evaluation, pilots and commercials.
View Detail
15 2-((4-(2-Methoxyethyl)phenoxy)methyl)oxirane
Manus Aktteva offers Metoprolol Intermediate,56718-70-8, 2-((4-(2-Methoxyethyl)phenoxy)methyl)oxirane,for your requirements of evaluation, pilots and commercials.
View Detail
Previous 1 - 15 | 16 - 30 | 31 - 45 | 46 - 60 | 61 - 75 | 76 - 76 | Next
NOTE: 
  • Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
       Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
  • Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
        Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS: 
  • => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
        => Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
© 2012 MANUS AKTTEVA  All rights reserved..
Payment Procedure